INTRODUCTION: The growth hormone deficiency (GHD) diagnosis is controversial especially due to low specificity of growth hormone (GH) stimulation tests. It is therefore believed that children diagnosed with GHD form a heterogeneous group with growth disorder frequently independent on GH function. No study evaluating the complex etiology of growth failure in children with diagnosed GHD has been performed thus far. AIMS: To discover genetic etiology of short stature in children with diagnosed GHD from families with short stature. METHODS: Fifty-two children diagnosed with primary GHD and vertically transmitted short stature (height SDS in the child and his/her shorter parent <-2 SD) were included to our study. The GHD diagnosis was based on growth data suggestive of GHD, absence of substantial disproportionality (sitting height to total height ratio <-2 SD or >+2 SD), IGF-1 levels <0 for age and sex specific SD and peak GH concentration <10 ug/L in two stimulation tests. All children were examined using next-generation sequencing methods, and the genetic variants were subsequently evaluated by American College of Medical Genetics standards and guidelines. RESULTS: The age of children at enrollment into the study was 11 years (median, IQR 9-14 years), their height prior to GH treatment was -3.0 SD (-3.6 to -2.8 SD), IGF-1 concentration -1.4 SD (-2.0 to -1.1 SD), and maximal stimulated GH 6.3 ug/L (4.8-7.6 ug/L). No child had multiple pituitary hormone deficiency or a midbrain region pathology. Causative variant in a gene that affects growth was discovered in 15/52 (29%) children. Of them, only 2 (13%) had a genetic variant affecting GH secretion or function (GHSR and OTX2). Interestingly, in 10 (67%) children we discovered a primary growth plate disorder (ACAN, COL1A2, COL11A1, COL2A1, EXT2, FGFR3, NF1, NPR2, PTPN11 [2x]), in one (7%) a genetic variant impairing IGF-1 action (IGFALS) and in two (12%) a variant in miscellaneous genes (SALL4, MBTPS2). CONCLUSIONS: In children with vertically transmitted short stature, genetic results frequently did not correspond with the clinical diagnosis of GH deficiency. These results underline the doubtful reliability of methods standardly used to diagnose GH deficiency.

Department of Pediatrics of 2nd Faculty of Medicine Charles University Prague and Motol University Hospital Prague Czechia

Zobrazit více v PubMed

Ogilvy-Stuart AL. Growth hormone deficiency (GHD) from birth to 2 years of age: Diagnostic specifics of GHD during the early phase of life. Horm Res Paediatr (2003) 60:2–9. doi: 10.1159/000071219 PubMed DOI

Hage C, Gan H-W, Ibba A, Patti G, Dattani M, Loche S, et al. . Advances in differential diagnosis and management of growth hormone deficiency in children. Nat Rev Endocrinol (2021) 17:608–24. doi: 10.1038/s41574-021-00539-5 PubMed DOI

Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, et al. . Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: Growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr (2016) 86:361–97. doi: 10.1159/000452150 PubMed DOI

Society GR. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH research society 1. J Clin Endocrinol Metab (2000) 85(11):3990–3. doi: 10.1210/jcem.85.11.6984 PubMed DOI

Murray PG, Dattani MT, Clayton PE. Controversies in the diagnosis and management of growth hormone deficiency in childhood and adolescence. Arch Dis Child (2016) 101:96–100. doi: 10.1136/archdischild-2014-307228 PubMed DOI

Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, et al. . Reliability of provocative tests to assess growth hormone secretory status. study in 472 normally growing children. J Clin Endocrinol Metab (1996) 81:3323–7. doi: 10.1210/jc.81.9.3323 PubMed DOI

Allen DB. Diagnosis of growth hormone deficiency remains a judgment call – and that is good. Horm Res Paediatr (2021) 94:406–9. doi: 10.1159/000521628 PubMed DOI

Tornese G. Growth hormone deficiency’ or rather ‘short stature unresponsive to stimulation tests. Arch Dis Child (2022) archdischild–2021–323426. doi: 10.1136/archdischild-2021-323426 PubMed DOI PMC

Dauber A, Rosenfeld RG, Hirschhorn JN. Genetic evaluation of short stature. J Clin Endocrinol Metab (2014) 99:3080–92. doi: 10.1210/jc.2014-1506 PubMed DOI PMC

Hattori A, Katoh-Fukui Y, Nakamura A, Matsubara K, Kamimaki T, Tanaka H, et al. . Next generation sequencing-based mutation screening of 86 patients with idiopathic short stature. Endocr J (2017) 64:947–54. doi: 10.1507/endocrj.EJ17-0150 PubMed DOI

Plachy L, Strakova V, Elblova L, Obermannova B, Kolouskova S, Snajderova M, et al. . High prevalence of growth plate gene variants in children with familial short stature treated with growth hormone. J Clin Endocrinol Metab (2019) 104:4273–81. doi: 10.1210/jc.2018-02288 PubMed DOI

Voigt M, Fusch C, Olbertz D, Hartmann K, Rochow N, Renken C, et al. . Analyse des neugeborenenkollektivs der bundesrepublik deutschland. Geburtshilfe Frauenheilkd (2006) 66:956–70. doi: 10.1055/s-2006-924458 DOI

Kobzová J, Vignerová J, Bláha P, Krejćovsky L, Riedlová J. The 6th nationwide anthropological survey of children and adolescents in the Czech republic in 2001. Cent Eur J Public Health (2004) 12:126–30. PubMed

Fredriks AM, van Buuren S, van Heel WJM, Dijkman-Neerincx RHM, Verloove-Vanhorick SP, Wit JM. Nationwide age references for sitting height, leg length, and sitting height/height ratio, and their diagnostic value for disproportionate growth disorders. Arch Dis Child (2005) 90:807–12. doi: 10.1136/adc.2004.050799 PubMed DOI PMC

Tanner J, Healy M, Goldstein H, Cameron N. Assessment of skeletal maturity and prediction of adult height (TW3 method). 3rd ed. London: Saunders Ltd. (2001).

Pruhova S, Dusatkova P, Sumnik Z, Kolouskova S, Pedersen O, Hansen T, et al. . Glucokinase diabetes in 103 families from a country-based study in the Czech republic: Geographically restricted distribution of two prevalent GCK mutations. Pediatr Diabetes (2010) 11:529–35. doi: 10.1111/j.1399-5448.2010.00646.x PubMed DOI

Plachy L, Dusatkova P, Maratova K, Petruzelkova L, Zemkova D, Elblova L, et al. . NPR2 variants are frequent among children with familiar short stature and respond well to growth hormone therapy. J Clin Endocrinol Metab (2020) 105:e746–52. doi: 10.1210/clinem/dgaa037 PubMed DOI

Plachy L, Dusatkova P, Maratova K, Petruzelkova L, Elblova L, Kolouskova S, et al. . Familial short stature - a novel phenotype of growth plate collagenopathies. J Clin Endocrinol Metab (2021) 106:1742–9. doi: 10.1210/clinem/dgab084 PubMed DOI

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. . Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med (2015) 17:405–24. doi: 10.1038/gim.2015.30 PubMed DOI PMC

Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R, et al. . VarSome: the human genomic variant search engine. Bioinformatics (2019) 35:1978–80. doi: 10.1093/bioinformatics/bty897 PubMed DOI PMC

Jarvik GP, Browning BL. Consideration of cosegregation in the pathogenicity classification of genomic variants. Am J Hum Genet (2016) 98:1077–81. doi: 10.1016/j.ajhg.2016.04.003 PubMed DOI PMC

Alatzoglou KS, Webb EA, le Tissier P, Dattani MT. Isolated growth hormone deficiency (GHD) in childhood and adolescence: Recent advances. Endocr Rev (2014) 35:376–432. doi: 10.1210/er.2013-1067 PubMed DOI

Bright GM, Morris PA, Rosenfeld RG. When is a positive test for pediatric growth hormone deficiency a true-positive test? Horm Res Paediatr (2021) 94:399–405. doi: 10.1159/000521281 PubMed DOI

Etiology of combined pituitary hormone deficiency: GNAO1 as a novel candidate gene